Pages that link to "Q46620153"

The following pages link to Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast (Q46620153):

Displaying 29 items.

• Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands (Q24676232) (← links)
• Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast (Q28265668) (← links)
• A rare presentation of triple-negative apocrine breast carcinoma with metastases (Q33612920) (← links)
• Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database (Q33648568) (← links)
• Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes (Q34006749) (← links)
• FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. (Q34497523) (← links)
• Cutaneous apocrine carcinoma in groin with bilateral lymph node metastasis: a case report and review of the literature (Q34733366) (← links)
• A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin. (Q35088185) (← links)
• Apocrine carcinoma of the male breast: a case report of an exceptional tumor (Q35373734) (← links)
• Sonography of Invasive Apocrine Carcinoma of the Breast in Five Cases (Q36026804) (← links)
• Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? (Q36113793) (← links)
• Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. (Q36456638) (← links)
• Atypical breasts cancers (Q36758092) (← links)
• Squamous cell carcinoma with apocrine features of the breast: A case report (Q37575140) (← links)
• Benign and malignant apocrine lesions of the breast. (Q37982447) (← links)
• The classification of invasive carcinoma of the breast (Q38132239) (← links)
• Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy (Q38405459) (← links)
• Molecular and diagnostic features of apocrine breast lesions. (Q38537958) (← links)
• High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy (Q38869310) (← links)
• Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort (Q41130064) (← links)
• Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast (Q41130687) (← links)
• 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. (Q42439006) (← links)
• Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation (Q43246075) (← links)
• Immunophenotyping of male breast cancer (Q43891146) (← links)
• Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients (Q46773052) (← links)
• Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype. (Q46827099) (← links)
• Cytological diagnostic clues in poorly differentiated squamous cell carcinomas of the breast: Streaming arrangement, necrotic background, nucleolar enlargement and cannibalism of cancer cells. (Q48134452) (← links)
• Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast (Q54638064) (← links)
• Prolactin-induced protein (PIP)-characterization and role in breast cancer progression (Q90573145) (← links)